Sarcopenia — the age-related loss of skeletal muscle mass and function — accelerates after age 50, affecting strength, balance, metabolic health and longevity. Conventional approaches focus on resistance training and adequate protein intake, but bioregulator peptides offer additional cellular-level support.
Gotratix is a Khavinson peptide bioregulator extracted from young muscle tissue. The short peptide signals are designed to enter satellite cells and myofibres, supporting the renewal cycle that maintains muscle quality. Published research suggests benefits in maintaining muscle protein synthesis and recovery capacity.
Athletes use Gotratix to support recovery between intense training cycles. Older adults use it as part of a sarcopenia prevention protocol alongside resistance exercise and 1.2–1.6 g/kg daily protein intake. Post-injury recovery is another common application, supporting tissue regeneration after surgery or strain.
Suggested protocol: 1–2 capsules daily for 30 days, repeated 2–4 times per year. Gotratix combines well with Sigumir (cartilage peptide) for joint-muscle synergy and with Cerluten (brain peptide) to support neuromuscular signalling.
No significant side effects have been reported in the bioregulator literature. Gotratix is suitable for healthy adults; those with diagnosed muscle disorders should consult their physician.
